A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 81 Dimensions

Readers on

mendeley: 42 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 412 followers.

A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation. https://t.co/XgA32WgAA3

27 Aug 2019

Reply Repost Favourite

A small molecule inhibitor MCC950 ameliorates kidney injury in diabeti | DMSO @DovePress https://t.co/UGUuMS1rvl

03 Aug 2019